What was the first plant alkaloid ever isolated?

Morphine is generally recognised as the first plant alkaloid isolated in the modern sense, extracted from opium poppies by Friedrich Sertürner around 1804. He used acid-base extraction techniques and identified a crystalline compound he initially called principium somniferum. The method he developed became the template for alkaloid isolation across the following decades.

Are cannabinoids the same as alkaloids?

No. Alkaloids are nitrogen-containing compounds with a basic (alkaline) chemical character. Cannabinoids — including THC and CBD — are terpenophenolics, a structurally distinct class. The isolation techniques developed for alkaloids influenced later plant chemistry broadly, but cannabinoids belong to a different chemical family entirely.

How long did it take to understand how isolated alkaloids actually worked in the body?

Often over a century. Morphine was isolated in around 1804, but its primary receptor target — the mu-opioid receptor — wasn't characterised until 1976. Similarly, THC was isolated and structurally described in 1964, but the CB1 receptor it interacts with wasn't identified until 1988. Isolation consistently preceded mechanistic understanding by decades.

Why did pure isolated compounds change medicine so significantly?

Before isolation, plant medicines were variable in concentration and composition from batch to batch. A pure compound can be weighed, standardised, and administered at a reproducible dose — which is the foundation of rational prescribing and pharmaceutical safety regulation. This principle underpins modern regulatory frameworks, including the TGA's Good Manufacturing Practice requirements and the Poisons Standard scheduling system in Australia.

Does isolating a compound from a plant mean we lose something from the whole plant?

That's an active area of research and genuine scientific debate. The hypothesis that multiple compounds in a plant matrix interact in ways an isolated compound does not replicate — sometimes framed as the entourage effect in cannabinoid science — has attracted serious research interest. However, the evidence base remains complex and contested. Isolation offers reproducibility and dosing precision; whole-plant extracts retain complexity that may or may not be pharmacologically significant. Current research hasn't resolved this conclusively.

Isolation of the First Plant Alkaloids

By Hannah Bui · 10 May 2026 · 7 min read

Sometime around 1804, a young German pharmacist's apprentice named Friedrich Sertürner dissolved something from dried poppy heads in acid, then in ammonia, and watched crystals form. He called the substance principium somniferum. We know it now as morphine. It was, as far as historians of chemistry can verify, the first time a pure active compound had ever been isolated from a plant in the modern sense , separated from everything else, named, weighed, reproducible.

That moment didn't just give medicine a new drug. It gave medicine a new concept: that the biological effect of a plant could be attributed to a single isolable molecule rather than to some ineffable vital force in the whole plant. That shift in thinking is still reverberating, 220 years later, in debates about full-spectrum versus isolated extracts, about what we lose when we pull one compound out of context. I'll come back to that tension, because I think it's one of the most underappreciated arguments in plant medicine.

What an alkaloid actually is

The term alkaloid was coined by the pharmacist Carl Friedrich Wilhelm Meissner in 1819, just a few years after Sertürner's isolation, to describe nitrogen-containing plant compounds that are basic (alkaline) in the chemical sense , they react with acids to form salts, which is precisely what made them extractable using the acid-base technique Sertürner and his contemporaries were refining.

Alkaloids are not a single chemical family. They include everything from simple structures like caffeine to the far more complex strychnine, quinine, and codeine. What they share is nitrogen embedded in a ring structure, and a tendency to have pronounced biological activity in animals. Plants produce them , though exactly why remains a live research question; as secondary metabolites; likely as defence against herbivores, possibly as signalling molecules, possibly both.

Honestly, I find the "why do plants make these things" question more interesting than most people give it credit for. The short version is: we still don't fully know.

The isolation race: 1804 to the 1830s

Once Sertürner's method circulated through European chemistry, the pace of discovery was remarkable. A rough timeline:

1817, Strychnine isolated from Strychnos nux-vomica by Pelletier and Caventou (though disputed in part by earlier French work)
1820, Quinine isolated from cinchona bark by Pelletier and Caventou; this one mattered enormously for colonial-era medicine and for understanding malaria's biology decades later
1828; Nicotine isolated from tobacco by Posselt and Reimann
1833, Atropine isolated from belladonna (Atropa belladonna) by Mein
1860, Cocaine isolated from coca leaves by Albert Niemann

Each isolation followed roughly the same logic: take a plant with a known folk or traditional use, apply acid-base extraction chemistry, and identify the fraction responsible for the observed effect. The approach was almost audaciously reductionist, and it worked brilliantly; for a while.

The chemistry they were working with

It's worth pausing on the technical reality of early 19th-century chemistry, because the story is sometimes told as though these were obvious steps. They weren't. Sertürner's lab, by modern standards, had almost nothing. No spectroscopy, no chromatography, no mass spectrometry, the tools we now use routinely to identify and quantify compounds (including standardised extracts) simply did not exist.

What early alkaloid chemists had was meticulous gravimetric analysis: weigh the starting material, weigh the product at each stage, observe the reactions. They confirmed identity largely through melting point, crystal morphology, and the reactions they caused in animals or in themselves. Sertürner tested morphine on himself and three young volunteers. That is not, to put it mildly, how we do things now.

Structural elucidation, actually drawing out the arrangement of atoms; came much later. The full structure of morphine wasn't established until 1925, by John Gulland and Robert Robinson, over a century after the isolation. Quinine's structure followed in 1944. The gap between "we have isolated a pure compound" and "we know exactly what that compound looks like" is something that gets collapsed in popular retellings.

Why purity changed everything

Before isolation, plant medicines were inherently variable. A tincture of opium from one batch of poppies might be twice as concentrated as another. Dosing was guesswork calibrated by experience, and experience varied by practitioner. Once you had morphine as a crystal, a measurable, reproducible substance, you could, in principle, know exactly how much you were giving. Dosing became rational in a way it hadn't been before.

This is the same logic that still underpins pharmaceutical regulation today. The TGA's requirements for Good Manufacturing Practice exist because reproducibility and purity are non-negotiable for safety. The idea that pure, quantified active compounds are safer than raw plant material in variable forms traces a direct line back to Sertürner's crystals.

That said; and this is the tension I flagged at the top, the reductionist assumption that one compound = one effect has not always held. It turned out plants are more complicated than that. The isolation of individual compounds from cannabis, for instance, eventually required researchers to grapple with the fact that the plant contains over a hundred structurally distinct cannabinoids alongside a large library of terpenes and other constituents. Whether those components interact meaningfully is a question that has generated significant ongoing research interest under the framing of the entourage effect.

From alkaloids to the broader picture

Alkaloids were the first class of plant compounds to be systematically isolated, but they're not the only ones, and by the mid-20th century chemists were isolating compounds from very different structural families. Cannabinoids, which are not alkaloids; they're terpenophenolics; became a focus of serious isolation chemistry in the 1960s. Raphael Mechoulam and Yechiel Gaoni at the Hebrew University of Jerusalem isolated and described the structure of tetrahydrocannabinol in 1964, and cannabidiol had been structurally characterised slightly earlier, in 1963.

The cannabinoid isolation work followed the same intellectual template: identify the active fraction from a complex plant matrix, purify, characterise. But it also raised the same questions the early alkaloid chemists couldn't fully answer: what exactly is this compound doing, and to what target? The alkaloid chemists knew their compounds had effects; the receptor systems those compounds acted on weren't characterised until much later. Morphine's primary receptor target, the mu-opioid receptor, wasn't named until 1976. The endocannabinoid system, including the CB1 and CB2 receptors that THC interacts with, wasn't described until the late 1980s and early 1990s.

Isolation, in other words, preceded mechanistic understanding by decades; sometimes over a century. I find this a useful corrective to the assumption that isolating something and naming it is the same as understanding it. We named morphine in 1804. We were still arguing about how it worked in 1976.

The Australian regulatory thread

A little closer to home: the regulatory frameworks that now govern how isolated plant compounds are assessed in Australia, the Therapeutic Goods Administration's scheduling under the Poisons Standard, are philosophically downstream of exactly this history. Schedule 8 controlled drugs, for instance, include many isolated alkaloids (or their derivatives): morphine, codeine in higher concentrations, oxycodone. The Schedule 8 category exists because pure isolated compounds with significant biological activity at known doses require a higher level of control than, say, a herbal tea.

The Poisons Standard's approach is, in a sense, Sertürner's logic codified into law: we schedule the pure compound, not the plant. A poppy in your garden is not scheduled. Morphine is.

How pharmacokinetics research; how a compound moves through the body after isolation and dosing, became possible is also a direct descendant of this era. You can't meaningfully study how a body absorbs, distributes, metabolises and excretes a compound if you don't have that compound in pure form to start with.

What the history actually shows

I was sorting through some op-shop finds last winter, the kind of afternoon where you end up reading a battered 1970s pharmacology textbook for two hours; and the thing that struck me was how the early alkaloid chapters read with such confidence. Pure compound, known dose, observed effect. The messiness of receptor biology, of individual variation, of the plant matrix, was largely absent.

That confidence was partly justified and partly premature. The isolation of plant alkaloids was a genuine scientific revolution: it made pharmacology as a discipline possible, created the conditions for rational dosing, and ultimately gave rise to the modern pharmaceutical supply chain. But the reductionist framework it embedded, one molecule, one target, one effect, has been complicated by nearly every decade of research since.

The history of plant compound isolation is less a straight line of progress and more a series of cycles: isolate, assume you understand, discover a new layer of complexity, revise. We're still in that process. The endocannabinoidome, the expanding recognition that compounds like anandamide and related molecules operate within dense signalling networks, is the latest iteration of the same revision.

Friedrich Sertürner didn't know any of that. He just wanted to know what made poppies work. Fair enough, really.

Sources

, Hannah Bui, Evidence & research-literacy writer

Common questions

What was the first plant alkaloid ever isolated?: Morphine is generally recognised as the first plant alkaloid isolated in the modern sense, extracted from opium poppies by Friedrich Sertürner around 1804. He used acid-base extraction techniques and identified a crystalline compound he initially called principium somniferum. The method he developed became the template for alkaloid isolation across the following decades.
Are cannabinoids the same as alkaloids?: No. Alkaloids are nitrogen-containing compounds with a basic (alkaline) chemical character. Cannabinoids — including THC and CBD — are terpenophenolics, a structurally distinct class. The isolation techniques developed for alkaloids influenced later plant chemistry broadly, but cannabinoids belong to a different chemical family entirely.
How long did it take to understand how isolated alkaloids actually worked in the body?: Often over a century. Morphine was isolated in around 1804, but its primary receptor target — the mu-opioid receptor — wasn't characterised until 1976. Similarly, THC was isolated and structurally described in 1964, but the CB1 receptor it interacts with wasn't identified until 1988. Isolation consistently preceded mechanistic understanding by decades.
Why did pure isolated compounds change medicine so significantly?: Before isolation, plant medicines were variable in concentration and composition from batch to batch. A pure compound can be weighed, standardised, and administered at a reproducible dose — which is the foundation of rational prescribing and pharmaceutical safety regulation. This principle underpins modern regulatory frameworks, including the TGA's Good Manufacturing Practice requirements and the Poisons Standard scheduling system in Australia.
Does isolating a compound from a plant mean we lose something from the whole plant?: That's an active area of research and genuine scientific debate. The hypothesis that multiple compounds in a plant matrix interact in ways an isolated compound does not replicate — sometimes framed as the entourage effect in cannabinoid science — has attracted serious research interest. However, the evidence base remains complex and contested. Isolation offers reproducibility and dosing precision; whole-plant extracts retain complexity that may or may not be pharmacologically significant. Current research hasn't resolved this conclusively.